Northwestern Medicine investigators have discovered previously unknown metabolic changes that may contribute to the ...

Research from Weill Cornell Medicine has identified a molecular pathway linking omega-6 linoleic acid—a common dietary fat in ...

From soy’s supposed ability to impact hormones to processed soy foods “poisoning” our food system, there’s someone, somewhere ...

Vepdegestrant is an investigational, orally bioavailable PROTAC (PROteolysis TArgeting Chimera) protein degrader designed to specifically target and degrade the estrogen receptor (ER) for the ...

Relay Therapeutics, Inc.’s RLAY share price has dipped by 12.66%, which has investors questioning if this is right time to ...

PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative ...

On Tuesday, based on data from those with estrogen receptor 1 (ESR1m) mutations, the duo said that the protein degrader reached the primary endpoint in their Phase 3 VERITAC-2 trial designed to ...

Researchers at UCSF discovered that regulatory T cells (T-regs) in the meninges produce natural opioids, and their ...

New research reveals how anthocyanin-rich fruits and vegetables could help defend your body against toxic microplastic ...

Pfizer (NYSE:PFE) and its partner Arvinas (NASDAQ:ARVN) for the experimental breast cancer drug vepdegestrant announced mixed initial results from a Phase 3 trial for the protein degrader on Tuesday.